Hongbin Luo

519 total citations
11 papers, 403 citations indexed

About

Hongbin Luo is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Hongbin Luo has authored 11 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cell Biology and 4 papers in Genetics. Recurrent topics in Hongbin Luo's work include Dermatological and Skeletal Disorders (3 papers), Skin and Cellular Biology Research (3 papers) and Ubiquitin and proteasome pathways (2 papers). Hongbin Luo is often cited by papers focused on Dermatological and Skeletal Disorders (3 papers), Skin and Cellular Biology Research (3 papers) and Ubiquitin and proteasome pathways (2 papers). Hongbin Luo collaborates with scholars based in China, United States and Sweden. Hongbin Luo's co-authors include Ye Feng, Xiaochuan Wang, Jian–Zhi Wang, Guang Yu, Yiyuan Xia, Zan-Chao Liu, Keqiang Ye, Xinghua Liu, Jun Jiang and Kuan Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Investigative Dermatology and Neurobiology of Aging.

In The Last Decade

Hongbin Luo

10 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongbin Luo China	8	223	135	76	75	66	11	403
Michael Orthofer Austria	5	350 1.6×	187 1.4×	52 0.7×	53 0.7×	51 0.8×	5	502
Alain Schilb Switzerland	8	364 1.6×	195 1.4×	57 0.8×	53 0.7×	126 1.9×	10	516
Edra London United States	12	212 1.0×	109 0.8×	50 0.7×	42 0.6×	55 0.8×	26	469
Abraham D. Lee United States	8	342 1.5×	202 1.5×	73 1.0×	82 1.1×	38 0.6×	11	579
Aino Mutka Finland	9	245 1.1×	134 1.0×	91 1.2×	53 0.7×	23 0.3×	18	456
Alexander Jaschke Germany	10	131 0.6×	72 0.5×	85 1.1×	78 1.0×	39 0.6×	12	377
Isabel Castro‐Piedras United States	13	345 1.5×	74 0.5×	41 0.5×	51 0.7×	105 1.6×	31	560
Anna Zoccarato United Kingdom	12	547 2.5×	118 0.9×	75 1.0×	34 0.5×	22 0.3×	19	677
Amanda Knoten United States	5	305 1.4×	195 1.4×	29 0.4×	116 1.5×	48 0.7×	7	584
Emilia Zmuda‐Trzebiatowska Sweden	8	302 1.4×	119 0.9×	48 0.6×	24 0.3×	32 0.5×	9	453

Countries citing papers authored by Hongbin Luo

Since Specialization

Citations

This map shows the geographic impact of Hongbin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Luo more than expected).

Fields of papers citing papers by Hongbin Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Luo. The network helps show where Hongbin Luo may publish in the future.

Co-authorship network of co-authors of Hongbin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbin Luo. A scholar is included among the top collaborators of Hongbin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbin Luo. Hongbin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ye, Changqing, Jing Leng, Yong Meng, et al.. (2025). SysNatMed: rational natural medicine discovery by systems genetics. Frontiers in Pharmacology. 16. 1496061–1496061.

Liu, Fei, et al.. (2023). Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta‐analysis. Journal of Cosmetic Dermatology. 22(9). 2408–2419. 3 indexed citations

Huang, Jianhe, Hongbin Luo, Jagmohan Singh, et al.. (2021). Functional Assessment of Missense Variants in the ABCC6 Gene Implicated in Pseudoxanthoma Elasticum, a Heritable Ectopic Mineralization Disorder. Journal of Investigative Dermatology. 142(4). 1085–1093. 1 indexed citations

Luo, Hongbin, et al.. (2020). Molecular Genetics and Modifier Genes in Pseudoxanthoma Elasticum, a Heritable Multisystem Ectopic Mineralization Disorder. Journal of Investigative Dermatology. 141(5). 1148–1156. 16 indexed citations

Luo, Hongbin, Qiaoli Li, Yi Cao, & Jouni Uitto. (2020). Therapeutics Development for Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders: Update 2020. Journal of Clinical Medicine. 10(1). 114–114. 24 indexed citations

Yang, Xiaohong, et al.. (2019). The Potential Role of Cycloastragenol in Promoting Diabetic Wound Repair In Vitro. BioMed Research International. 2019. 1–10. 12 indexed citations

Liu, Zan-Chao, Jiang Chu, Lin Li, et al.. (2015). SIL1 Rescued Bip Elevation-Related Tau Hyperphosphorylation in ER Stress. Molecular Neurobiology. 53(2). 983–994. 29 indexed citations

Luo, Hongbin, Yiyuan Xia, Xiji Shu, et al.. (2014). SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proceedings of the National Academy of Sciences. 111(46). 16586–16591. 180 indexed citations

Yu, Guang, Ye Feng, Xinghua Liu, et al.. (2013). Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease. Neurobiology of Aging. 34(7). 1748–1758. 53 indexed citations

10.

Wang, Zhida, Cuiping Bao, Weili Xu, et al.. (2013). Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis. Journal of Diabetes Investigation. 4(6). 659–666. 10 indexed citations

11.

Bao, Cuiping, Xilin Yang, Weili Xu, et al.. (2013). Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis. Journal of Diabetes and its Complications. 27(4). 357–364. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact